ThermoLife International, owner of 23 US Patents with more than 450 claims related to amino acid and nitrate compounds, compositions, and uses, announced today that the USPTO has issued new "Notices of Allowance" for three of its pending applications. ThermoLife will soon be awarded three new patents (with 160 new claims) on compositions and uses of amino acid nitrate compounds (including creatine nitrate), bringing the total number of claims on the use of nitrates in ThermoLife's patent portfolio to over 700.
In addition to these issuing patents, ThermoLife was also notified of claims pending in additional applications that have been confirmed allowable, signifying additional forthcoming Notices of Allowance and patent awards. These claims are directed to even more compositions for amino acid nitrate compounds, including creatine nitrate. For example, these newly confirmed patentable claims include patent protection for the following composition:
A supplement formulation for human ingestion comprising: creatine nitrate; and one or more additional components selected from the group consisting of a carrier, an excipient, a binder, a colorant, a flavoring agent, a preservative, a buffer, and a dilutant.
Accordingly, with the imminent issuance of the new patents, any product that includes creatine nitrate along with any one of a carrier, an excipient, a binder, a colorant, a flavoring agent, a preservative, a buffer, or a dilutant, will infringe on at least the foregoing claim.
These newly approved claims legally and effectively give ThermoLife patent coverage for any practical use of creatine nitrate in dietary supplements and will once and for all shut the door to any possible unauthorized and/or any unlicensed use of creatine nitrate in dietary supplements.
By the time all of the newly approved claims in these pending applications are issued in patents, ThermoLife anticipates its patent portfolio will have over 1,000 patented claims on the use of nitrates for dietary supplements in its portfolio.